| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,992 |
7,642 |
$1.87M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,040 |
2,966 |
$702K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,389 |
5,390 |
$685K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,376 |
3,243 |
$563K |
| 80053 |
Comprehensive metabolic panel |
8,579 |
8,076 |
$539K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
932 |
921 |
$526K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,358 |
4,202 |
$491K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,282 |
3,150 |
$413K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,174 |
1,108 |
$335K |
| 36415 |
Collection of venous blood by venipuncture |
9,900 |
9,096 |
$266K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,790 |
1,649 |
$249K |
| 99215 |
Prolong outpt/office vis |
2,297 |
2,240 |
$239K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
452 |
443 |
$209K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
855 |
843 |
$187K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,429 |
1,428 |
$165K |
| 81025 |
|
2,282 |
2,204 |
$139K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,739 |
2,566 |
$126K |
| 70450 |
Computed tomography, head or brain; without contrast material |
326 |
316 |
$120K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,882 |
4,845 |
$116K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,743 |
9,710 |
$112K |
| 80061 |
Lipid panel |
4,187 |
4,174 |
$105K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
247 |
241 |
$99K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,304 |
1,303 |
$99K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
831 |
815 |
$98K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,344 |
1,312 |
$88K |
| 95806 |
|
397 |
395 |
$82K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
283 |
280 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,368 |
2,303 |
$67K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,221 |
4,206 |
$65K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
907 |
342 |
$64K |
| 71046 |
Radiologic examination, chest; 2 views |
1,877 |
1,842 |
$63K |
| 71271 |
|
110 |
110 |
$57K |
| Q3014 |
Telehealth originating site facility fee |
1,312 |
1,304 |
$53K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
780 |
775 |
$45K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,974 |
1,972 |
$39K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,774 |
3,385 |
$37K |
| 80051 |
|
846 |
828 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
265 |
263 |
$33K |
| 86850 |
|
536 |
525 |
$31K |
| 73564 |
|
594 |
550 |
$30K |
| 76830 |
Ultrasound, transvaginal |
154 |
153 |
$29K |
| 73630 |
|
748 |
710 |
$28K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
307 |
163 |
$27K |
| 82607 |
|
1,237 |
1,235 |
$27K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
354 |
185 |
$26K |
| 84439 |
|
1,620 |
1,608 |
$26K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
690 |
593 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,270 |
1,156 |
$22K |
| 85027 |
|
1,861 |
1,792 |
$21K |
| 73610 |
|
634 |
614 |
$19K |
| 73030 |
|
390 |
371 |
$19K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
485 |
484 |
$18K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
781 |
776 |
$17K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
375 |
259 |
$16K |
| 86803 |
|
559 |
554 |
$15K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
83 |
81 |
$14K |
| 86900 |
|
623 |
609 |
$13K |
| 86901 |
|
622 |
608 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
543 |
542 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
86 |
73 |
$11K |
| 82565 |
|
1,286 |
1,251 |
$11K |
| 83735 |
|
2,665 |
2,436 |
$10K |
| 86140 |
|
960 |
930 |
$10K |
| 84450 |
|
1,927 |
1,866 |
$10K |
| 84466 |
|
642 |
635 |
$10K |
| 83540 |
|
854 |
839 |
$8K |
| 85610 |
|
938 |
703 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,121 |
1,854 |
$8K |
| 82728 |
|
362 |
358 |
$8K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
200 |
200 |
$8K |
| 97161 |
|
76 |
76 |
$7K |
| 84460 |
|
519 |
507 |
$7K |
| 97162 |
|
55 |
55 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
922 |
884 |
$7K |
| 85652 |
|
1,034 |
1,017 |
$6K |
| 84520 |
|
887 |
858 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
920 |
885 |
$6K |
| 83690 |
|
2,891 |
2,713 |
$6K |
| 73110 |
|
205 |
191 |
$6K |
| 72110 |
|
55 |
55 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
279 |
279 |
$5K |
| 73130 |
|
184 |
173 |
$5K |
| 81003 |
|
1,779 |
1,536 |
$4K |
| 20610 |
|
27 |
24 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
269 |
236 |
$4K |
| 81001 |
|
2,442 |
2,312 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
51 |
51 |
$4K |
| 82570 |
|
270 |
263 |
$3K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
76 |
76 |
$3K |
| 84702 |
|
262 |
215 |
$3K |
| 92567 |
|
111 |
111 |
$2K |
| 83880 |
|
74 |
73 |
$2K |
| 84484 |
|
1,774 |
1,488 |
$2K |
| 84153 |
|
76 |
76 |
$2K |
| 77080 |
|
13 |
13 |
$2K |
| 86618 |
|
245 |
242 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,137 |
1,059 |
$2K |
| 92557 |
|
42 |
42 |
$2K |
| 82947 |
|
507 |
497 |
$2K |
| 80377 |
|
12 |
12 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
12 |
12 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
42 |
42 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
108 |
58 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,141 |
1,996 |
$1K |
| 82247 |
|
1,261 |
1,211 |
$1K |
| 87634 |
|
49 |
49 |
$1K |
| 83655 |
|
128 |
128 |
$1K |
| 86780 |
|
90 |
90 |
$1K |
| 87340 |
|
66 |
64 |
$1K |
| 17110 |
|
15 |
15 |
$982.25 |
| 82040 |
|
1,202 |
1,161 |
$967.41 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$965.60 |
| 83520 |
|
91 |
91 |
$926.07 |
| 80076 |
|
16 |
16 |
$824.18 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
59 |
56 |
$770.14 |
| 87081 |
|
333 |
331 |
$752.79 |
| 90715 |
|
25 |
25 |
$738.78 |
| 11721 |
|
25 |
25 |
$626.77 |
| 84480 |
|
25 |
24 |
$585.33 |
| 82043 |
|
51 |
51 |
$583.76 |
| 87476 |
|
32 |
31 |
$533.21 |
| 83550 |
|
72 |
72 |
$451.13 |
| 90686 |
|
14 |
14 |
$327.76 |
| 87468 |
|
12 |
12 |
$326.60 |
| 85379 |
|
24 |
24 |
$313.38 |
| 84155 |
|
743 |
719 |
$278.87 |
| 83605 |
|
126 |
114 |
$274.32 |
| 87469 |
|
12 |
12 |
$249.28 |
| 87484 |
|
12 |
12 |
$249.28 |
| 87478 |
|
12 |
12 |
$249.28 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
89 |
87 |
$201.63 |
| 87077 |
|
40 |
39 |
$191.86 |
| 82784 |
|
15 |
14 |
$164.91 |
| 73590 |
|
12 |
12 |
$159.50 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
103 |
98 |
$159.11 |
| 86617 |
|
30 |
15 |
$156.54 |
| 86666 |
|
24 |
13 |
$152.50 |
| 82950 |
|
13 |
12 |
$150.41 |
| 82948 |
|
196 |
147 |
$138.71 |
| 86038 |
|
12 |
12 |
$117.08 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
114 |
81 |
$112.41 |
| 86753 |
|
13 |
13 |
$92.75 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,015 |
937 |
$86.17 |
| 82248 |
|
14 |
12 |
$77.61 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,255 |
2,073 |
$68.54 |
| J3490 |
Unclassified drugs |
59 |
58 |
$68.46 |
| 87186 |
|
14 |
14 |
$56.84 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
261 |
260 |
$33.10 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,247 |
1,178 |
$32.01 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
138 |
132 |
$24.05 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
25 |
24 |
$17.91 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
117 |
113 |
$2.38 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
14 |
14 |
$0.62 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
47 |
44 |
$0.10 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
25 |
25 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
59 |
49 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
13 |
13 |
$0.00 |